Intrapericardial fibrynolytic therapy in purulent pericarditis

European Journal of Cardio-thoracic Surgery

Volumn 22, Issue 3, 2002, Pages 373-376

  Üstünsoy, Haşim ^a   Celkan, Mehmet Adnan ^a   Sivrikoz, Muammer Cumhur ^a   Kazaz, Hakki ^a   Kilinç, Metin ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Fibrinolytic; Purulent pericarditis

Indexed keywords

ANTIBIOTIC AGENT; FIBRINOLYTIC AGENT; STREPTOKINASE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CLOTTING TIME; CATHETER; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LOCAL ANESTHESIA; MALE; PARTIAL THROMBOPLASTIN TIME; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; PERICARDIUM; PRIORITY JOURNAL; PROTHROMBIN TIME; SEPSIS; TREATMENT OUTCOME; ECHOGRAPHY; MIDDLE AGED; PRESCHOOL CHILD; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FIBRINOLYTIC AGENTS; HUMANS; MIDDLE AGED; PERICARDIOCENTESIS; PERICARDITIS; STAPHYLOCOCCAL INFECTIONS; STREPTOKINASE; THROMBOLYTIC THERAPY; VANCOMYCIN;

EID: 0036708389     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(02)00258-0     Document Type: Article

References (13)

1. Defouilloy C., Meyer G., Slama M., Galy C., Verhaeghe P., Touati G., Ossart M. Intrapericardial fibrynolysis: a useful treatment in the management of purulent pericarditis. Intensive Care Med. 23:1997;117-118.
2. Braunwald E. Pericardial disease. Heart disease. 1992;1492 Saunders Company, London.
3. Rubin R.H., Moellering R.C. Clinical, microbiological and therapeutic aspects of purulent pericarditis. Am J Med. 59:1975;68-78.
4. Hier-Madsen K., Suanomaki K.I., Wulff J. Purulent pericarditis in children. Review and case report. Scand J Thorac Cardiovasc Surg. 19:1985;185.
5. Karjalainen J. Streptococcal tonsillitis and acute non-rheumatic myopericarditis. Chest. 95:1989;359-363.
6. Schuh F. Erfahrungen über die paracentese der Brust und des Herzbeutels. Medzinisches Jahrbuch Kaiserlichen Königlichen Staates Wien. 33:1841;388.
7. Tillet W.S., Sherry S., Read T. The use of Streptokinase- Streptodornase in the treatment of post pneumonic empyema. J Thorac Cardiovasc Surg. 21:1951;275-297.
8. Fraedrich G., Hofmann D., Efferhauser P., Jarder R. Instillation of fibrynolytic enzymes in the treatment of pleural empyema. Thorac Cardiovasc Surg. 30:1982;36-38.
9. Berglin E., Ekroth R., Teger-Nilson A.C., William-Olsson G. Intrapleural instillation of Streptokinase: effects on systemic fibrynolysis. Thorac Cardiovasc Surg. 29:1981;124-126.
10. Marder V.J., Sherry S. Trombolytic therapy: current status. N Engl J Med. 318:1988;1512-1520.
11. Cross J.H., De Giovanni J.V., Silove E. Use of streptokinase to aid in drainage of postoperative pericardial effusion. Br Heart J. 62:1989;217-219.
12. Juneja R., Kothari S.S., Saxena A., Sharma R., Joshi A. Intrapericardial streptokinase in purulent pericarditis. Arch Dis Child. 80:1999;275-277.
13. Aye R.W., Froese D.P., Hill L.D. Use of purified streptokinase in empyema and hemothoraks. Am J Surg. 161:1991;560-562.